Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer

Summary

This phase II trial is studying the side effects and how well ixabepilone works in treating patients with persistent or recurrent uterine cancer. Drugs used in chemotherapy, such as ixabepilone, work in different ways to stop the growth of tumor cells, either by killing the cells of by stopping them from dividing.

Timeline

Start

2010-09-07

Primary completion

2013-11-26

Completion

2013-11-26

Drugs

Indications